[ALNY] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
23-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- -32.64%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Annual Result
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 2,248,243 1,828,292 1,037,418 844,287 492,853 219,750 74,908 76.19%
PBT -178,939 -433,517 -1,126,993 -852,144 -855,600 -885,253 -760,674 -21.41%
Tax 99,218 6,725 4,163 680 2,681 863 823 122.10%
NP -278,157 -440,242 -1,131,156 -852,824 -858,281 -886,116 -761,497 -15.43%
Tax Rate - - - - - - - -
Total Cost 2,526,400 2,268,534 2,168,574 1,697,111 1,351,134 1,105,866 836,405 20.21%
Ratio Analysis
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -12.37 -24.08 -109.04 -101.01 -174.15 -403.24 -1,016.58 -52.00%
Per Share
31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -2.16 -3.52 -9.30 -7.20 -7.46 -8.11 -7.57 -18.84%
EPS Diluted -2.16 -3.52 -9.30 -7.20 -7.46 -8.11 -7.57 -18.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.